However, because mutations in MYOC are not generally causal for glaucoma, pathogenicity is currently considered only with prioritized clinical metrics, and where available, laboratory data, such as that curated by ClinGen (https://www.clinicalgenome.org) and related projects (https://myocilin.com) (Hewitt et al., 2008). This evidence concerns the gene MYOC and glaucoma.